Mergers & Acquisitions Mergers & Acquisitions

Elanco, Bayer say most players CADE queried are positive or neutral about their deal

By Ana Paula Candil
  • 09 Apr 2020 16:16
  • 09 Apr 2020 16:16
Elanco Animal Health and Bayer have told the Brazilian competition authority that a market inquiry conducted by the agency has shown that their deal won't harm competition. 
The parties said that most of the 63 players who have responded to the agency so far presented neutral or positive opinions about

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Ana Paula Candil

Senior Correspondent, Latin America

Ana Paula joined MLex in Brazil in 2014 writing about antitrust investigations and merger reviews. Prior to that, she worked for several trade publications and in TV. She lived in Washington DC, where she worked for Al Jazeera English in 2010. She studied journalism and holds a postgraduate diploma in International Business Management from the George Brown College in Toronto and a Master of Business Administration diploma in government relations from Fundação Getúlio Vargas (FGV).

Discover MLex

Stay on top of global regulatory developments

Latest News